Literature DB >> 16944929

Protein bipartivity and essentiality in the yeast protein-protein interaction network.

Ernesto Estrada1.   

Abstract

Protein-protein interaction networks (PINs) are structured by means of a few highly connected proteins linked to a large number of less-connected ones. Essential proteins have been found to be more abundant among these highly connected proteins. Here we demonstrate that the likelihood that removal of a protein in a PIN will prove lethal to yeast correlates with the lack of bipartivity of the protein. A protein is bipartite if it can be partitioned in such a way that there are two groups of proteins with intergroup, but not intragroup, interactions. The abundance of essential proteins found among the least bipartite proteins clearly exceeds that found among the most connected ones. For instance, among the top 50 proteins ranked by their lack of bipartivity 62% are essential proteins. However, this percentage is only 38% for proteins ranked according to their number of interactions. Protein bipartivity also surpasses another 5 measures of protein centrality in yeast PIN in identifying essential proteins and doubles the number of essential proteins selected at random. We propose a possible mechanism for the evolution of essential proteins in yeast PIN based on the duplication-divergence scheme. We conclude that a replica protein evolving from a nonbipartite target will also be nonbipartite with high probability. Consequently, these new replicas evolving from nonbipartite (essential) targets will with high probability be essential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944929     DOI: 10.1021/pr060106e

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  13 in total

1.  Drug repositioning using disease associated biological processes and network analysis of drug targets.

Authors:  Sachin Mathur; Deendayal Dinakarpandian
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Proteome-wide prediction of self-interacting proteins based on multiple properties.

Authors:  Zhongyang Liu; Feifei Guo; Jiyang Zhang; Jian Wang; Liang Lu; Dong Li; Fuchu He
Journal:  Mol Cell Proteomics       Date:  2013-02-18       Impact factor: 5.911

Review 3.  In silico Methods for Identification of Potential Therapeutic Targets.

Authors:  Xuting Zhang; Fengxu Wu; Nan Yang; Xiaohui Zhan; Jianbo Liao; Shangkang Mai; Zunnan Huang
Journal:  Interdiscip Sci       Date:  2021-11-26       Impact factor: 3.492

4.  Topological network measures for drug repositioning.

Authors:  Apurva Badkas; Sébastien De Landtsheer; Thomas Sauter
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

5.  A network flow approach to predict drug targets from microarray data, disease genes and interactome network - case study on prostate cancer.

Authors:  Shih-Heng Yeh; Hsiang-Yuan Yeh; Von-Wun Soo
Journal:  J Clin Bioinforma       Date:  2012-01-13

6.  Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition.

Authors:  Xiaolin Xiao; Neil Dawson; Lynsey Macintyre; Brian J Morris; Judith A Pratt; David G Watson; Desmond J Higham
Journal:  BMC Syst Biol       Date:  2011-05-16

7.  Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network.

Authors:  Tilahun Melak; Sunita Gakkhar
Journal:  Clin Transl Med       Date:  2015-06-05

8.  Rechecking the Centrality-Lethality Rule in the Scope of Protein Subcellular Localization Interaction Networks.

Authors:  Xiaoqing Peng; Jianxin Wang; Jun Wang; Fang-Xiang Wu; Yi Pan
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

9.  How to identify essential genes from molecular networks?

Authors:  Gabriel del Rio; Dirk Koschützki; Gerardo Coello
Journal:  BMC Syst Biol       Date:  2009-10-13

Review 10.  Topology of molecular interaction networks.

Authors:  Wynand Winterbach; Piet Van Mieghem; Marcel Reinders; Huijuan Wang; Dick de Ridder
Journal:  BMC Syst Biol       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.